News
Livecoaching mit Meerblick gibt es jeden Morgen um 7.17 Uhr im NDR 2 Morgen bei Elke & Jens - hier alle Infos zur NDR 2 Comedy. mehr ...
In the preceding three months, 6 analysts have released ratings for Vir Biotechnology VIR, presenting a wide array of perspectives from bullish to bearish. The following table summarizes their ...
US pharma major Pfizer (NYSE: PFE) is stepping up its presence in the high-stakes field of bispecific immuno-oncology with a licensing deal worth up to $6 billion for a Chinese-developed drug that ...
(AP Photo/Barbara Ortutay, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...
SAN FRANCISCO, May 19, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback